Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Campylobacter levels in fresh chicken remain steady
3.8 per cent of chickens across the major retailers tested positive for the highest level of contamination.
Major retailers publish their latest results

Levels of campylobacter in fresh shop-bought chickens have remained steady for the January-March 2018 results, according to the Food Standards Agency (FSA).

On average, latest figures show 3.8 per cent of chickens across the major retailers tested positive for the highest level of contamination. These are chickens that carry more than 1,000 colony forming units per gram (cfu/g) of Campylobacter.

"The latest figures are consistent with previous results and show we are consolidating on the significant progress made so far,” commented Michael Wight, director of policy and science at the FSA. “We will continue to actively work with retailers and smaller poultry businesses to further reduce campylobacter levels.

"We would like to thank the major retailers and poultry producers for their efforts in tackling campylobacter and for working alongside the FSA to coordinate the publication of results.”

The FSA has been testing chickens for campylobacter since February 2014 and publishing the results as part of a wider campaign to tackle the problem. Campylobacter is the most common cause of food poisoning in the UK.

Since 21 September, major retailers have been carrying out their own sampling and publishing the results under regulation laid down by the FSA. The FSA said that it is continuing to sample chickens sold at retail, but stressed that the focus is now on the smaller retailers and independent market. 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.